{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T07:36:59Z","timestamp":1779003419197,"version":"3.51.4"},"reference-count":70,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.iac.2022.05.012","type":"journal-article","created":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T07:05:04Z","timestamp":1666940704000},"page":"117-132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Management of Allergic Skin Disorders in Pregnancy"],"prefix":"10.1016","volume":"43","author":[{"given":"Eleanor M.","family":"Pope","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leah","family":"Laageide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa A.","family":"Beck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.iac.2022.05.012_bib2","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1111\/jdv.15709","article-title":"European task force on atopic dermatitis position paper: treatment of parental atopic dermatitis during preconception, pregnancy and lactation period","volume":"33","author":"Vestergaard","year":"2019","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.iac.2022.05.012_bib3","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.mcna.2019.08.012","article-title":"Allergic contact dermatitis","volume":"104","author":"Nassau","year":"2020","journal-title":"Med Clin North Am"},{"issue":"7","key":"10.1016\/j.iac.2022.05.012_bib4","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/all.13397","article-title":"The EAACI\/GA2LEN\/EDF\/WAO guideline for the definition, classification, diagnosis and management of urticaria","volume":"73","author":"Zuberbier","year":"2018","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.iac.2022.05.012_bib5","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/j.jaip.2020.03.030","article-title":"Urticaria and angioedema across the ages","volume":"8","author":"Saini","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.iac.2022.05.012_bib6","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jaci.2011.06.010","article-title":"A\u00a0randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria","volume":"128","author":"Saini","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2022.05.012_bib7","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1046\/j.1365-2133.2000.03664.x","article-title":"Randomized double-blind study of cyclosporin in chronic 'idiopathic' urticaria","volume":"143","author":"Grattan","year":"2000","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.iac.2022.05.012_bib8","doi-asserted-by":"crossref","first-page":"e14475","DOI":"10.1111\/dth.14475","article-title":"New emergent therapies for atopic dermatitis: a review of safety profile with respect to female fertility, pregnancy, and breastfeeding","volume":"34","author":"Napolitano","year":"2021","journal-title":"Dermatol Ther"},{"issue":"10","key":"10.1016\/j.iac.2022.05.012_bib9","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.jdcr.2020.08.001","article-title":"Dupilumab for the treatment of severe atopic dermatitis in a pregnant patient: a case report","volume":"6","author":"Mian","year":"2020","journal-title":"JAAD Case Rep"},{"issue":"19","key":"10.1016\/j.iac.2022.05.012_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20194660","article-title":"The roles of sex hormones in the course of atopic dermatitis","volume":"20","author":"Kanda","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"7611","key":"10.1016\/j.iac.2022.05.012_bib11","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/bmj.39227.671227.AE","article-title":"Eczema in pregnancy","volume":"335","author":"Weatherhead","year":"2007","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.iac.2022.05.012_bib12","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.amjms.2016.05.030","article-title":"Allergy medications during pregnancy","volume":"352","author":"Gonzalez-Estrada","year":"2016","journal-title":"Am J Med Sci"},{"issue":"5","key":"10.1016\/j.iac.2022.05.012_bib13","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ijwd.2021.10.002","article-title":"Novel systemic treatments in atopic dermatitis: are there sex differences?","volume":"7","author":"Tuttle KLF","year":"2021","journal-title":"Int J Women\u2019s Dermatol"},{"key":"10.1016\/j.iac.2022.05.012_bib14","article-title":"Lack of association between atopic dermatitis severity and worsening during pregnancy: a cross-sectional study","author":"Rakita","year":"2021","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.iac.2022.05.012_bib15","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/jdv.15256","article-title":"Pregnancy complications, treatment characteristics and birth outcomes in women with atopic dermatitis in Denmark","volume":"33","author":"Hamann","year":"2019","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.iac.2022.05.012_bib16","doi-asserted-by":"crossref","first-page":"401.e1-14","DOI":"10.1016\/j.jaad.2013.09.010","article-title":"Safety of dermatologic medications in pregnancy and lactation: Part I. Pregnancy","volume":"70","author":"Murase","year":"2014","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.iac.2022.05.012_bib17","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1001\/archderm.136.8.999","article-title":"Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European tacrolimus ointment study group","volume":"136","author":"Reitamo","year":"2000","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1016\/j.iac.2022.05.012_bib18","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jaad.2005.06.013","article-title":"Pharmacokinetics of topical calcineurin inhibitors in adult atopic dermatitis: a randomized, investigator-blind comparison","volume":"53","author":"Draelos","year":"2005","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.iac.2022.05.012_bib19","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/ced.14567","article-title":"Janus kinase inhibitors for atopic dermatitis: a promising treatment modality","volume":"46","author":"Cartron","year":"2021","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.iac.2022.05.012_bib20","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jgar.2019.07.032","article-title":"Mupirocin resistance in Staphylococcus aureus: a systematic review and meta-analysis","volume":"20","author":"Dadashi","year":"2020","journal-title":"J\u00a0Glob Antimicrob Resist"},{"issue":"4","key":"10.1016\/j.iac.2022.05.012_bib21","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s10103-011-0895-0","article-title":"Effect of narrowband ultraviolet B phototherapy on serum folic acid levels in patients with psoriasis","volume":"26","author":"El-Saie","year":"2011","journal-title":"Lasers Med Sci"},{"issue":"1","key":"10.1016\/j.iac.2022.05.012_bib22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ibd.22948","article-title":"Systematic review and meta-analysis on the effects of thiopurines on birth outcomes from female and male patients with inflammatory bowel disease","volume":"19","author":"Akbari","year":"2013","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"10.1016\/j.iac.2022.05.012_bib23","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jaci.2011.09.005","article-title":"Histamine and H1-antihistamines: celebrating a century of progress","volume":"128","author":"Simons","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2022.05.012_bib24","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1159\/000515246","article-title":"Atopic dermatitis treated safely with dupilumab during pregnancy: a case report and review of the literature","volume":"13","author":"Lobo","year":"2021","journal-title":"Case Rep Dermatol"},{"issue":"3","key":"10.1016\/j.iac.2022.05.012_bib25","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/bjd.19574","article-title":"Tralokinumab for moderate-to-severe atopic dermatitis: results from two 52-week, randomized, double-blind, multicentre, placebo-controlled phase III trials (ECZTRA 1 and ECZTRA 2)","volume":"184","author":"Wollenberg","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.iac.2022.05.012_bib26","article-title":"The International EAACI\/GA2LEN\/EuroGuiDerm\/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria","author":"Zuberbier","year":"2021","journal-title":"Allergy"},{"issue":"12","key":"10.1016\/j.iac.2022.05.012_bib27","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.autrev.2017.10.003","article-title":"Autoimmune comorbidity in chronic spontaneous urticaria: a systematic review","volume":"16","author":"Kolkhir","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"10","key":"10.1016\/j.iac.2022.05.012_bib28","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1111\/all.14950","article-title":"Effects of pregnancy on chronic urticaria: results of the PREG-CU UCARE study","volume":"76","author":"Kocat\u00fcrk","year":"2021","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.iac.2022.05.012_bib29","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/all.14037","article-title":"Prevalence of chronic urticaria in children and adults across the globe: systematic review with meta-analysis","volume":"75","author":"Fricke","year":"2020","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.iac.2022.05.012_bib30","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/all.12338","article-title":"Chronic urticaria in Chinese population: a hospital-based multicenter epidemiological study","volume":"69","author":"Zhong","year":"2014","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.iac.2022.05.012_bib31","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1365-2133.2008.08920.x","article-title":"Chronic urticaria: an internet survey of health behaviours, symptom patterns and treatment needs in European adult patients","volume":"160","author":"Maurer","year":"2009","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.iac.2022.05.012_bib32","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2310\/7750.2008.08035","article-title":"Etiologic aspects and prognostic factors of patients with chronic urticaria: nonrandomized, prospective, descriptive study","volume":"13","author":"Gregoriou","year":"2009","journal-title":"J\u00a0Cutan Med Surg"},{"issue":"4","key":"10.1016\/j.iac.2022.05.012_bib33","first-page":"279","article-title":"[Epidemiologic features in patients with antihistamine-resistant chronic urticaria]","volume":"62","author":"S\u00e1nchez Borges","year":"2015","journal-title":"Rev Alerg Mex"},{"issue":"4","key":"10.1016\/j.iac.2022.05.012_bib34","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.jaip.2017.10.030","article-title":"Serum IgE as an immunological marker to predict response to omalizumab treatment in symptomatic chronic urticaria","volume":"6","author":"Straesser","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"1\u20132","key":"10.1016\/j.iac.2022.05.012_bib35","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.imlet.2010.06.003","article-title":"Estrogen receptor profiles in human peripheral blood lymphocytes","volume":"132","author":"Pierdominici","year":"2010","journal-title":"Immunol Lett"},{"issue":"5","key":"10.1016\/j.iac.2022.05.012_bib36","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1111\/bjd.13621","article-title":"Elevations in T-helper-2-initiating cytokines (interleukin-33, interleukin-25 and thymic stromal lymphopoietin) in lesional skin from chronic spontaneous ('idiopathic') urticaria","volume":"172","author":"Kay","year":"2015","journal-title":"Br J Dermatol"},{"issue":"8","key":"10.1016\/j.iac.2022.05.012_bib37","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/cea.12348","article-title":"Calcitonin gene-related peptide and vascular endothelial growth factor are expressed in lesional but not uninvolved skin in chronic spontaneous urticaria","volume":"44","author":"Kay","year":"2014","journal-title":"Clin Exp Allergy"},{"issue":"6","key":"10.1016\/j.iac.2022.05.012_bib38","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/j.jaip.2021.03.033","article-title":"The pathogenesis of chronic spontaneous urticaria: the role of infiltrating cells","volume":"9","author":"Gim\u00e9nez-Arnau","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.iac.2022.05.012_bib39","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s12016-017-8631-6","article-title":"Sex, symptom severity, and quality of life in rheumatology","volume":"56","author":"Krasselt","year":"2019","journal-title":"Clin Rev Allergy Immunol"},{"issue":"5","key":"10.1016\/j.iac.2022.05.012_bib40","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000507218","article-title":"Urticaria: Collegium Internationale Allergologicum (CIA) update 2020","volume":"181","author":"Maurer","year":"2020","journal-title":"Int Arch Allergy Immunol"},{"issue":"3","key":"10.1016\/j.iac.2022.05.012_bib41","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/cei.13428","article-title":"Co-occurrence of IgE and IgG autoantibodies in patients with chronic spontaneous urticaria","volume":"200","author":"Asero","year":"2020","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"10.1016\/j.iac.2022.05.012_bib42","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1067\/mai.2002.123236","article-title":"TH1\/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction","volume":"109","author":"Ying","year":"2002","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.iac.2022.05.012_bib43","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/ACI.0b013e32833c79d7","article-title":"Effectiveness of Helicobacter pylori eradication in chronic urticaria: evidence-based analysis using the grading of recommendations assessment, development, and evaluation system","volume":"10","author":"Shakouri","year":"2010","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.iac.2022.05.012_bib44","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1172\/JCI122182","article-title":"Regulatory T\u00a0cells in embryo implantation and the immune response to pregnancy","volume":"128","author":"Robertson","year":"2018","journal-title":"J\u00a0Clin Invest"},{"issue":"5","key":"10.1016\/j.iac.2022.05.012_bib45","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/archderm.141.5.601","article-title":"Hormonal effect on psoriasis in pregnancy and post partum","volume":"141","author":"Murase","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.iac.2022.05.012_bib46","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3389\/fimmu.2014.00231","article-title":"Mast cell-mediated and associated disorders in pregnancy: a risky game with an uncertain outcome?","volume":"5","author":"Woidacki","year":"2014","journal-title":"Front Immunol"},{"issue":"2\u20133","key":"10.1016\/j.iac.2022.05.012_bib47","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1159\/000235300","article-title":"Modulation of rat peritoneal mast cell and human basophil histamine release by estrogens","volume":"93","author":"Cocchiara","year":"1990","journal-title":"Int Arch Allergy Appl Immunol"},{"issue":"1","key":"10.1016\/j.iac.2022.05.012_bib48","doi-asserted-by":"crossref","first-page":"e462","DOI":"10.1038\/cddis.2012.214","article-title":"Mast cells rescue implantation defects caused by c-kit deficiency","volume":"4","author":"Woidacki","year":"2013","journal-title":"Cell Death Dis"},{"issue":"8","key":"10.1016\/j.iac.2022.05.012_bib49","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1016\/j.molimm.2006.09.030","article-title":"Estradiol activates mast cells via a non-genomic estrogen receptor-alpha and calcium influx","volume":"44","author":"Zaitsu","year":"2007","journal-title":"Mol Immunol"},{"issue":"1","key":"10.1016\/j.iac.2022.05.012_bib50","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1289\/ehp.9378","article-title":"Environmental estrogens induce mast cell degranulation and enhance IgE-mediated release of allergic mediators","volume":"115","author":"Narita","year":"2007","journal-title":"Environ Health Perspect"},{"issue":"12","key":"10.1016\/j.iac.2022.05.012_bib51","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1111\/j.1398-9995.2006.01185.x","article-title":"Lower serum concentration of dehydroepiandrosterone sulphate in patients suffering from chronic idiopathic urticaria","volume":"61","author":"Kasperska-Zajac","year":"2006","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.iac.2022.05.012_bib52","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3904\/kjim.2008.23.4.176","article-title":"Effects of dehydroepiandrosterone on Th2 cytokine production in peripheral blood mononuclear cells from asthmatics","volume":"23","author":"Choi","year":"2008","journal-title":"Korean J Intern Med"},{"issue":"1","key":"10.1016\/j.iac.2022.05.012_bib53","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.iac.2013.09.006","article-title":"Urticaria and angioedema in pregnancy and lactation","volume":"34","author":"Lawlor","year":"2014","journal-title":"Immunol Allergy Clin N Am"},{"issue":"6","key":"10.1016\/j.iac.2022.05.012_bib54","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1067\/mjd.2000.104517","article-title":"UVA rush hardening for the treatment of solar urticaria","volume":"42","author":"Beissert","year":"2000","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.iac.2022.05.012_bib55","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jaci.2015.06.021","article-title":"Approaches to the diagnosis and management of patients with a history of nonsteroidal anti-inflammatory drug-related urticaria and angioedema","volume":"136","author":"Kowalski","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.iac.2022.05.012_bib56","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/cea.12494","article-title":"BSACI guideline for the management of chronic urticaria and angioedema","volume":"45","author":"Powell","year":"2015","journal-title":"Clin Exp Allergy"},{"issue":"Suppl 86","key":"10.1016\/j.iac.2022.05.012_bib57","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1398-9995.2007.01620.x","article-title":"Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)","volume":"63","author":"Bousquet","year":"2008","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.iac.2022.05.012_bib58","first-page":"1","article-title":"The maddening itch: an approach to chronic urticaria","volume":"24","author":"Viegas","year":"2014","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2022.05.012_bib59","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jaci.2011.04.038","article-title":"Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase","volume":"128","author":"Maurer","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2022.05.012_bib60","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s12016-020-08794-6","article-title":"Omalizumab updosing in chronic spontaneous urticaria: an overview of real-world evidence","volume":"59","author":"Metz","year":"2020","journal-title":"Clin Rev Allergy Immunol"},{"issue":"4","key":"10.1016\/j.iac.2022.05.012_bib61","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jaad.2006.04.078","article-title":"Cyclosporine in chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial","volume":"55","author":"Vena","year":"2006","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.iac.2022.05.012_bib62","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2340\/0001555576295297","article-title":"Acute urticaria: clinical aspects and therapeutic responsiveness","volume":"76","author":"Zuberbier","year":"1996","journal-title":"Acta Derm Venereol"},{"issue":"Suppl 1","key":"10.1016\/j.iac.2022.05.012_bib63","first-page":"S1","article-title":"A\u00a0summary of the new International EAACI\/GA2LEN\/EDF\/WAO guidelines in urticaria","volume":"5","author":"Zuberbier","year":"2012","journal-title":"World Allergy Organ J"},{"issue":"1","key":"10.1016\/j.iac.2022.05.012_bib64","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1468-3083.2011.04185.x","article-title":"Pharmacological rationale for the treatment of chronic urticaria with second-generation non-sedating antihistamines at higher-than-standard doses","volume":"26","author":"Zuberbier","year":"2012","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.iac.2022.05.012_bib65","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1365-2222.2007.02678.x","article-title":"BSACI guidelines for the management of chronic urticaria and angio-oedema","volume":"37","author":"Powell","year":"2007","journal-title":"Clin Exp Allergy"},{"issue":"4","key":"10.1016\/j.iac.2022.05.012_bib66","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.jaip.2018.04.026","article-title":"Montelukast reduces symptom severity and frequency in patients with angioedema-predominant chronic spontaneous urticaria","volume":"6","author":"Akenroye","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.iac.2022.05.012_bib67","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jaci.2013.05.013","article-title":"Omalizumab in patients with symptomatic chronic idiopathic\/spontaneous urticaria despite standard combination therapy","volume":"132","author":"Kaplan","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.iac.2022.05.012_bib68","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/cea.12508","article-title":"Evidence that FcRn mediates the transplacental passage of maternal IgE in the form of IgG anti-IgE\/IgE immune complexes","volume":"45","author":"Bundhoo","year":"2015","journal-title":"Clin Exp Allergy"},{"issue":"2","key":"10.1016\/j.iac.2022.05.012_bib69","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jaci.2019.05.019","article-title":"Pregnancy outcomes in the omalizumab pregnancy registry and a disease-matched comparator cohort","volume":"145","author":"Namazy","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3 Suppl","key":"10.1016\/j.iac.2022.05.012_bib70","first-page":"S1","article-title":"Contact dermatitis: a practice parameter-update 2015","volume":"3","author":"Fonacier","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.iac.2022.05.012_bib71","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.jaad.2015.02.1139","article-title":"Allergic contact dermatitis: patient diagnosis and evaluation","volume":"74","author":"Mowad","year":"2016","journal-title":"J\u00a0Am Acad Dermatol"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856122000443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856122000443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:46:02Z","timestamp":1760179562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856122000443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S0889856122000443"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2022.05.012","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Allergic Skin Disorders in Pregnancy","name":"articletitle","label":"Article Title"},{"value":"Immunology and Allergy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iac.2022.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}